MedPath

Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease

Phase 2
Terminated
Conditions
Parkinson's Disease
Registration Number
NCT00643890
Lead Sponsor
Neurologix, Inc.
Brief Summary

The purpose of this study is to determine the safety and efficacy of AAV-GAD gene transfer into the subthalamic nucleus (STN) region of the brain. This study involves the treatment of subjects with medically refractory Parkinson's disease (PD). The gene transfer product, a disabled virus with a gene called GAD, will be infused into the STN bilaterally using stereotactic surgical techniques. The overall goal of this approach is to normalize the activity of the STN and reduce the motor symptoms of PD.

Because the change in UPDRS demonstrated a positive outcome, the sham surgery subjects from the blinded portion of the study will be invited to crossover into the Open-label Arm portion of the study. The Open-label Arm will further evaluate the safety and efficacy of AAV-GAD gene transfer into the subthalamic nucleus (STN) region of the brain.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Idiopathic Parkinson's disease
  • Duration of disease for at least 5 years
  • Levodopa responsiveness for at least 12 months
  • UPDRS Part 3 score ≥ 25 or more in "off" state
Exclusion Criteria
  • Past history of brain surgery for PD
  • Beck Depression Inventory Score ≥ 20
  • Any history of cerebral insult or central nervous system infection
  • Cognitive impairment score < 130 on the Mattis Dementia Rating Scale
  • Focal neurological deficits
  • Evidence of significant medical or psychiatric disorders
  • Secondary Parkinsonism
  • Atypical Parkinson's disease
  • History of substance abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate a change in UPDRS scores
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

University of Colorado

🇺🇸

Aurora, Colorado, United States

Wake Forest University Health Science Center

🇺🇸

Winston-Salem, North Carolina, United States

Stanford University

🇺🇸

Stanford, California, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

University of Rochester

🇺🇸

Rochester, New York, United States

The Ohio State University

🇺🇸

Columbus, Ohio, United States

Henry Ford Health Systems - Franklin Pointe Medical

🇺🇸

Southfield, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath